Cargando…
Systemic cell therapy for muscular dystrophies: The ultimate transplantable muscle progenitor cell and current challenges for clinical efficacy
The intrinsic regenerative capacity of skeletal muscle makes it an excellent target for cell therapy. However, the potential of muscle tissue to renew is typically exhausted and insufficient in muscular dystrophies (MDs), a large group of heterogeneous genetic disorders showing progressive loss of s...
Autores principales: | Ausems, C. Rosanne M., van Engelen, Baziel G.M., van Bokhoven, Hans, Wansink, Derick G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166694/ https://www.ncbi.nlm.nih.gov/pubmed/33349909 http://dx.doi.org/10.1007/s12015-020-10100-y |
Ejemplares similares
-
Intrinsic Myogenic Potential of Skeletal Muscle-Derived Pericytes from Patients with Myotonic Dystrophy Type 1
por: Ausems, Cornelia Rosanne Maria, et al.
Publicado: (2019) -
Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy
por: André, Laurène M., et al.
Publicado: (2018) -
CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities
por: Raaijmakers, Renée H.L., et al.
Publicado: (2019) -
Rasch analysis to evaluate the motor function measure for patients with facioscapulohumeral muscular dystrophy
por: Mul, Karlien, et al.
Publicado: (2020) -
Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy
por: Greco, Anna, et al.
Publicado: (2020)